首页> 外文期刊>The Journal of biological chemistry >After Embedding in Membranes Antiapoptotic Bcl-XL Protein Binds Both Bcl-2 Homology Region 3 and Helix 1 of Proapoptotic Bax Protein to Inhibit Apoptotic Mitochondrial Permeabilization
【24h】

After Embedding in Membranes Antiapoptotic Bcl-XL Protein Binds Both Bcl-2 Homology Region 3 and Helix 1 of Proapoptotic Bax Protein to Inhibit Apoptotic Mitochondrial Permeabilization

机译:在膜嵌入膜中,抗曝光BCL-XL蛋白结合Bcl-2同源区3和促凋亡Bax蛋白的螺旋1,以抑制凋亡的线粒体渗透

获取原文
           

摘要

Bcl-XL binds to Bax, inhibiting Bax oligomerization required for mitochondrial outer membrane permeabilization (MOMP) during apoptosis. How Bcl-XL binds to Bax in the membrane is not known. Here, we investigated the structural organization of Bcl-XL·Bax complexes formed in the MOM, including the binding interface and membrane topology, using site-specific cross-linking, compartment-specific labeling, and computational modeling. We found that one heterodimer interface is formed by a specific interaction between the Bcl-2 homology 1–3 (BH1–3) groove of Bcl-XL and the BH3 helix of Bax, as defined previously by the crystal structure of a truncated Bcl-XL protein and a Bax BH3 peptide (Protein Data Bank entry 3PL7). We also discovered a novel interface in the heterodimer formed by equivalent interactions between the helix 1 regions of Bcl-XL and Bax when their helical axes are oriented either in parallel or antiparallel. The two interfaces are located on the cytosolic side of the MOM, whereas helix 9 of Bcl-XL is embedded in the membrane together with helices 5, 6, and 9 of Bax. Formation of the helix 1·helix 1 interface partially depends on the formation of the groove·BH3 interface because point mutations in the latter interface and the addition of ABT-737, a groove-binding BH3 mimetic, blocked the formation of both interfaces. The mutations and ABT-737 also prevented Bcl-XL from inhibiting Bax oligomerization and subsequent MOMP, suggesting that the structural organization in which interactions at both interfaces contribute to the overall stability and functionality of the complex represents antiapoptotic Bcl-XL·Bax complexes in the MOM.
机译:Bcl-XL与Bax结合,抑制细胞凋亡期间线粒体外膜透化(MOMP)所需的Bax寡聚化。 BCL-XL如何结合在膜中的Bax未知。在这里,我们研究了在MOM中形成的BCL-XL·Bax络合物的结构组织,包括使用位点特异性交联,特定的盒式标记和计算建模的结合界面和膜拓扑。我们发现一种异二聚体界面是通过Bcl-2同源1-3(BH1-3)凹槽与BAX的BH3螺旋的BH3螺旋之间的特异性相互作用形成,如先前通过截短的BCL-的晶体结构所定义的XL蛋白和Bax BH3肽(蛋白质数据库条目3PL7)。我们还发现了在Bcl-XL和Bax的螺旋1区之间的等效相互作用形成的新型界面,当它们的螺旋轴线平行或反平行定向时。两个界面位于MOM的细胞溶质侧,而BCL-XL的螺旋9与Bax的螺旋5,6和9一起嵌入膜中。螺旋1·螺旋1界面部分取决于凹槽·BH3接口的形成,因为后一界面中的点突变和ABT-737的添加,沟槽结合BH3模拟物,阻塞了两个接口的形成。突变和ABT-737还防止了BCL-XL抑制Bax寡聚化和随后的MOMP,表明两个界面的相互作用有助于复合物的整体稳定性和功能的结构组织代表抗曝气BCL-XL·Bax复合物妈妈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号